4amj
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Turkey beta1 adrenergic receptor with stabilising mutations and bound biased agonist carvedilol== | ==Turkey beta1 adrenergic receptor with stabilising mutations and bound biased agonist carvedilol== | ||
<StructureSection load='4amj' size='340' side='right' caption='[[4amj]], [[Resolution|resolution]] 2.30Å' scene=''> | <StructureSection load='4amj' size='340' side='right' caption='[[4amj]], [[Resolution|resolution]] 2.30Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2CV:HEGA-10'>2CV</scene>, <scene name='pdbligand=CVD:(2S)-1-(8H-CARBAZOL-4-YLOXY)-3-[2-(2-METHOXYPHENOXY)ETHYLAMINO]PROPAN-2-OL'>CVD</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2CV:HEGA-10'>2CV</scene>, <scene name='pdbligand=CVD:(2S)-1-(8H-CARBAZOL-4-YLOXY)-3-[2-(2-METHOXYPHENOXY)ETHYLAMINO]PROPAN-2-OL'>CVD</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1dep|1dep]], [[2vt4|2vt4]], [[2y00|2y00]], [[2y01|2y01]], [[2y02|2y02]], [[2y03|2y03]], [[2y04|2y04]], [[2ycw|2ycw]], [[2ycx|2ycx]], [[2ycy|2ycy]], [[2ycz|2ycz]], [[4ami|4ami]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1dep|1dep]], [[2vt4|2vt4]], [[2y00|2y00]], [[2y01|2y01]], [[2y02|2y02]], [[2y03|2y03]], [[2y04|2y04]], [[2ycw|2ycw]], [[2ycx|2ycx]], [[2ycy|2ycy]], [[2ycz|2ycz]], [[4ami|4ami]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4amj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4amj OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4amj RCSB], [http://www.ebi.ac.uk/pdbsum/4amj PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4amj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4amj OCA], [http://pdbe.org/4amj PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4amj RCSB], [http://www.ebi.ac.uk/pdbsum/4amj PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4amj ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| Line 17: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4amj" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
Revision as of 22:53, 4 August 2016
Turkey beta1 adrenergic receptor with stabilising mutations and bound biased agonist carvedilol
| |||||||||||
